The global amniotic membrane market size is expected to be worth around US$ 6.81 billion by 2030, according to a new report by Vision Research Reports.
The global amniotic membrane market size is expected to be worth around US$ 6.81 billion by 2030, according to a new report by Vision Research Reports.
The global amniotic membrane market size was valued at US$ 3.26 billion in 2020 and is anticipated to grow at a CAGR of 14.7% during forecast period 2021 to 2030.
Immediate Delivery Available | Get the sample copy of report@ https://www.visionresearchreports.com/report/sample/37322
Growth Factors
Rise in trauma, burn cases and resulting surgeries along with increasing awareness regarding the benefits of these products are boosting the market growth. Rising number of cosmetic surgeries performed is also anticipated to drive the market during the forecast period. Amniotic membrane is also used in the treatment of a large number of ocular surface diseases as it protects surfaces from microbial colonization preventing the risk of infections.
Moreover, presence of growth factors including basic Fibroblast Growth Factor (bFGF), Transforming Growth Factors (TGFs), Epidermal Growth Factor (EGF), Vascular Endothelial Growth Factor (VEGF), Nerve Growth Factor (NGF), and Keratinocyte Growth Factor (KGF) in amniotic membranes promote wound healing, accelerating its adoption globally. Thus, its benefits, such as anti-inflammatory properties, reduced fibrosis and scarring at the site of surgery, pain reduction, and wound healing properties, are also fueling the demand. These products are thus most commonly used in surgeries, treatment of venous, pressure, and diabetic foot ulcers, ophthalmology, and in the management of chronic wounds.
Report Coverage
| Report Scope | Details |
| Market Size | US$ 6.81 billion by 2030 |
| Growth Rate | CAGR of 14.7% From 2022 to 2030 |
| Largest Market | North America |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Product, Application, End-use |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Mentioned | Alliqua BioMedical Inc.; Amnio Technology, LLC; Applied Biologics LLC; Human Regenerative Technologies, LLC; DermaSciences, Katena Products, Inc.; MiMedx Group Inc.; Skye Biologics, Inc.; Amniox Medical Inc.; Organogensis, Inc |
Report Highlights
Based on application, the market is segmented into surgical wounds, ophthalmology, and others. These products are most often used in ophthalmic surgeries to initiate faster recovery while reducing inflammation. These membranes are also used in reconstructive surgeries to reduce scarring and promote healing. According to estimates from the American Society of Plastic Surgeons, over 17.5 million surgical cosmetic procedures were performed in the U.S. in 2017. These facts are indicative of the rising number of individuals undergoing surgery to enhance their aesthetic appeal.
Thus, high product demand in cosmetic surgeries is boosting the market growth. These products are also used in reconstructive procedures, which is also propelling their demand. Usage of amniotic membranes for burn injury treatments enables rapid wound healing and epithelialization. It is also proven to reduce pain and facilitate easy movement of the affected area. Since the usage of this method proves to be cheaper than xenografts and allografts, it is increasingly being used across the globe, which is accelerating the segment growth.
On the basis of end use, the market is segmented into hospitals, Ambulatory Surgical Centers (ASCs), specialty clinics, and research and academic institutes. Hospitals are the primary care settings facilitating easy treatment for a wide range of diseases. These end use settings held the largest market share owing to frequent visits by patients and its ability to cater to a varied range of surgical interventions.
Rising use of amniotic membranes in ASCs is driving the segment growth. The use of these products is easy and effective and also facilitates wound recovery without frequent visits to hospitals or clinics. Thus, the ASC settings are also likely to witness rapid growth over the next few years.
Specialty clinics that are taken into consideration in the study are burn centers, plastic surgery clinics, dermatology clinics, and others. As most of these require methods to prevent infections and promote effective wound healing, the use of amniotic membranes is frequently seen in these settings facilitating market growth.
Research and academic institutes segment also holds a significant share in the amniotic membrane market owing to increasing R&D investments by major market players and hospitals to understand the possible product applications. The amniotic membrane provides a substrate for and can be used in various applications, propelling increasing research on the subject.
Based on, the market is segmented into cryopreserved and dehydrated amniotic membranes. Cryopreserved amniotic membrane held the largest market share owing to high effectivity and usage. The segment is anticipated to expand further at a lucrative CAGR over the forecast period. Cryopreserved membrane is typically stored in cell culture medium that contains 50% glycerol at a temperature of -80°C.
Dehydrated amniotic membranes, such as PalinGen, FlōGraft, AmbioDisk, and AmnioFix, are used for treating various surgical wounds, reconstruction procedures, and venous and pressure leg ulcers owing to properties, such as its ability to maintain a watertight seal, inhibit inflammatory responses, and prevent disease transmissions. Usually, these are used as a biological bandage to promote healing. All these factors are anticipated to fuel the segment development in the near future.
North America led the market in 2020. The presence of well-developed healthcare infrastructure and leading companies have fueled market growth in the region. Moreover, adoption of advanced technologies and increased focus on alternative technologies in this region is expected to drive the segment further.
The European region accounted for the second-highest revenue and is expected to witness a CAGR of 11.9% over the forecast years. The healthcare system in the European region is publicly funded and some countries have adopted universal health care systems. The presence of target population is the key factor propelling the region’s development.
Immediate Delivery Available | Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/37322
Market Dynamics
Market Drivers
- Incidents Of Burn Injuries Are Driving The Market
Demand for wound care biologics, especially amniotic membranes, has increased significantly as a result of the increasing prevalence of burn wounds. The bulk of burn cases, according to the WHO, occur in low- and middle-income nations, with roughly two-thirds of those instances occurring in the WHO regions of Africa and Southeast Asia. One million people in India, for instance, experience moderate to severe burns each year (Source: WHO). In other Southeast Asian nations like Bangladesh and Nepal, burn incidents are also common. Every year, moderate to severe burns affects an estimated 173,000 children in Bangladesh. 5% of all disabilities in Nepal are caused by burns, which are the second most frequent injury.
- The Rising Awareness And Investment Are Driving The Market
Over the course of the projection period, it is expected that initiatives such as escalating investments, a spike in partnerships and collaborations, and creative product development techniques would boost market expansion. As a surgical graft or a biological bandage for maintaining and treating wounds, amniotic membranes are commonly employed in one of two ways. By serving as a scaffold when utilized as a graft, these membranes help in re-epithelialization. In addition, rising consumer awareness of these advantages is predicted to fuel market expansion. Additionally, they are frequently employed in the treatment of conditions affecting the eye’s surface, including bacterial keratitis, corneal ulcers, cataract, glaucoma, bullous keratopathy, corneal degeneration, and ocular dystrophy, eyelid reconstruction, and a number of others. Substantial demand for these tissue-based products has been generated by the increase in the elderly population around the world, which has increased the number of ophthalmology surgeries.
Market Restraints
- Risks Involved With The Usage Restrict The Market
Since there is little chance of difficulties, amniotic membranes shouldn’t be handled carelessly. If the donors are not sufficiently screened for communicable diseases, the patient or the recipient of an amniotic membrane may transmit bacterial, viral, or fungal infections. If the membrane is processed outside of sterile settings or is kept in an unsuitable environment for storage, there may be additional dangers for the patient or recipient. Post amniotic membrane transplantation, incidence rates of 1.6% to 8.0% have been documented, with gram-positive isolates being the most often observed. Furthermore, repeated and repetitive transplantations may result in early amniotic membrane deterioration and cheese wiring, which is a concern in and of itself.
Market Opportunities
- R&D And The 21st Century Cures Act Will Bring In New Opportunities
The market is anticipated to grow as a result of a variety of factors, including a rise in the number of surgeries performed globally, significant R&D investments, and expanding stem cell and regenerative medicine research. Additionally, in December 2016, the US government approved The 21st Century Cures Act, making it a law. This new law was passed, among other things, to advance medical innovation and research into regenerative medicine. The Act contains a number of provisions that could affect the creation and approval of several products in the upcoming years. A fast-track approval procedure for innovative regenerative medicine products and therapies has also been established under this Act, along with a new “Regenerative Medicine Advanced Therapy” designation. The passage of this Act may pave the way for the US Food and Drug Administration to approve fresh regenerative medicine treatments and goods. It may also encourage further research and development in the area.
Key Market Trends
Surgical Wounds Segment is Expected to Grow Significantly Over the Forecast Period
Amniotic membrane has several antimicrobial and biological properties in corneal surgery, as it enhances epithelialization, reinforces adhesion of basal epithelial cells, maintains epithelial phenotype, and modulates the proliferation of normal corneal, conjunctival, and limbal fibroblast. These membranes also prevent apoptosis, as well as inhibit scarring, inflammation, and neovascularization. Thus, the advantages of the amniotic membranes in the Surgical wound segment by the application are expected to drive the growth of the segment.
The rise in the hospital admission of trauma cases has increased the demand for surgeries globally. And this is anticipated to increase the demand for usage and adoption of amniotic membranes for surgical wound healing. The recent development by global market players in the segment is increasing currently, which is driving the segment growth. For instance, in July 2020, Merakris, a regenerative medicine company developing wound-healing products for skin and eyes, launched a new skin-graft alternative to help protect and heal wounds. The Amniotic membrane allograft tissue is a thin slice of human amniotic tissue from the placenta donated at the time of child delivery. It has been used for nearly a century in surgical wound healing. Thus, the advances are expected to bolster the segment growth.
Furthermore, the National Safety Council (NSC) facts and figures for injury in the United States 2020 stated that bicycling accounted for about 426,000 injuries, the most among any category of sports and recreation. Exercise, with or without equipment, followed about 378,000 injuries, while ATV, moped, and minibike use with 230,000 injuries, and skateboard, scooter, and hoverboard use, with 218,00 injuries, ranked third and fourth, and these increasing number of injuries and trauma primarily require surgical wound healing which uses amniotic membranes most commonly. Thus, the increasing number of sports injuries boosted the market growth for the surgical wound segment in the forecast period.
Therefore, owing to the factors stated above, the surgical wounds segment is growing, and it is expected to have significant growth over the forecast period. Hence, driving the growth of the studied market.
Related Reports
- Soft Tissue Market Report 2022-2030 - https://www.visionresearchreports.com/soft-tissue-market/38745
- Arterial Cannula Market Report 2022-2030 - https://www.visionresearchreports.com/arterial-cannula-market/39727
- Conductive Ink Market Report 2022-2030 - https://www.visionresearchreports.com/conductive-ink-market/39670
Key Players
Alliqua BioMedical, Inc.; Amnio Technology, LLC; Applied Biologics LLC; Human Regenerative Technologies, LLC; DermaSciences; Katena Products, Inc.; MiMedx Group, Inc.; Skye Biologics, Inc.; Amniox Medical, Inc.; and Organogensis, Inc.
Market Segmentation
- Enzyme Outlook
- Cryopreserved
- Dehydrated
- Application Outlook
- Surgical Wounds
- Ophthalmology
- Others
- End-use Outlook
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Research Institutes and Academic Institutes
- Regional Outlook
- North America
- Europe
- Asia Pacific
- Latin America
- MEA
Click Here to View Full Report Table of Contents
Immediate Delivery Available | Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/37322
You can place an order or ask any questions, please feel free to contact at sales@visionresearchreports.com | +1 9197 992 333
Blog: https://www.novaoneadvisor.com/
Blog: https://qyresearchmedical.com/